Alector, Inc.

Stocks

ALEC

US0144421072

Market Closed - Nasdaq 01:30:00 16/10/2026 am IST			5-day change	1st Jan Change
1.910 ^USD	+1.60%		-0.52%	+22.44%

13/10	Alector, Inc. - Special Call
06/10	Alector Shares Rise After Licensing AL050 Program to Roche's Genentech	MT

Transcript : Alector, Inc. - Special Call

Published on 10/13/2026 at 10:35 pm IST - Modified on 10/14/2026 at 04:32 am IST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Good day, and thank you for standing by. Welcome to the Alector Pipeline Webinar, Advancing Next Generation Medicines for Neurodegeneration. [Operator

This article is reserved for our subscribers.

Subcribe
to read the article

Unlimited browsing across the entire site

Access to all news and data

US, Europe, and Asia portfolios

Ad-free reading

Pro Tools : expert screeners, historical financials, PDF reports, investment themes, and earnings transcripts

Latest news about Alector, Inc.

13/10	Alector, Inc. - Special Call
06/10	Alector Shares Rise After Licensing AL050 Program to Roche's Genentech	MT
05/10	Alector, Inc. And Genentech, Inc. Enter Global License Agreement For Brain Penetrant GCase Enzyme Replacement Therapy For Parkinsons Disease And Other Neurodegenerative Diseases	CI
05/10	Alector soars as Roche licenses Parkinson's therapy for up to $1.27 billion	RE
05/10	Alector Licenses AL050 Program to Roche's Genentech	MT
16/09	Novartis halts ALS drug development after mid-stage trial failure	RE
15/09	Alector, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-15-2026 07:00 AM
15/09	Alector, Inc. Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference, Sep-10-2026 02:10 PM
07/08	Alector, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
09/07	Wall Street Ignores the Sirens
09/07	GSK adds Royal Philips' Chief Executive Jakobs to board	AN
09/07	Oil keeps markets on edge
09/07	UK Stocks-Factors to watch on July 9	RE
09/07	Alector and GSK partnership to end after dementia, Alzheimer's drug failures	RE
09/07	Alector, Inc. Announces Termination of Collaboration Agreement with Glaxo Wellcome UK Limited	CI

Chart Alector, Inc.

Duration

Period

ALEC: Dynamic Chart

Company Profile

Sector

More about the company

Income Statement and Estimates

Projected Income Statement - Annual - Alector, Inc.

More financial data

Ratings

More Ratings

EPS Estimates

Evolution of Analysts' Estimates - EPS - Alector, Inc.

Revisions to estimates